Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

Eckert & Ziegler Strahlen- und Medizintechnik AG, DE0005659700

Eckert & Ziegler 2020: Earnings higher than expected

17.03.2021 - 23:54:12

Eckert & Ziegler 2020: Earnings higher than expected. Eckert & Ziegler Strahlen- und Medizintechnik AG, DE0005659700

Berlin, 17 March 2021. Based on preliminary, unaudited calculations Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) will exceed its current profit guidance of 1.00 EUR per share and be able to book profits of 1.11 EUR (previous year: 1.07 EUR) per share for the financial year 2020. The primary financial statements, the dividend recommendation, and the guidance for 2021 will be published after the Supervisory Board meeting on 25 March 2021. The complete audited annual report for the financial year 2020 will be published on 16 April 2021.

For enquiries please contact: Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-R?ssle-Str. 10, 13125 Berlin, Germany Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.com

17-March-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

Language: English Company: Eckert & Ziegler Strahlen- und Medizintechnik AG Robert-R?ssle-Str.10 13125 Berlin

Germany Phone: +49 30 941084-138 Fax: +49 30 941084-112 E-mail: karolin.riehle@ezag.de Internet: www.ezag.de ISIN: DE0005659700 WKN: 565970 Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange EQS News ID: 1176513 ? End of Announcement DGAP News Service

1176513??17-March-2021?CET/CEST

@ dgap.de